Evidence map›Paper›PMID 29867114›Full record

ArticleCell death & disease2018

Sorting nexin 10 controls mTOR activation through regulating amino-acid metabolism in colorectal cancer.

Yunchen Le, Sulin Zhang, Jiahui Ni, Yan You, Kejing Luo, Yunqiu Yu, Xiaoyan Shen

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Sorting nexin 10 knockdown: new strategies for alleviating sepsis-associated acute lung injury.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2026
    Article
  4. Article
  5. Unveiling SNX10: a key player in bladder cancer progression.Translational andrology and urology · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Effect of Early PathogenicFrontiers in cellular and infection microbiology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Construction and Analysis of Human Diseases and Metabolites Network.Frontiers in bioengineering and biotechnology · 2020
    Article
  16. Article
  17. The emerging role of sorting nexins in cardiovascular diseases.Clinical science (London, England : 1979) · 2019
    Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yunchen LeSchool of Pharmacy, Fudan University, Shanghai, 201203, PR China.
Sulin ZhangSchool of Pharmacy, Fudan University, Shanghai, 201203, PR China.
Jiahui NiSchool of Pharmacy, Fudan University, Shanghai, 201203, PR China.
Yan YouSchool of Pharmacy, Fudan University, Shanghai, 201203, PR China.
Kejing LuoSchool of Pharmacy, Fudan University, Shanghai, 201203, PR China.
Yunqiu YuSchool of Pharmacy, Fudan University, Shanghai, 201203, PR China. yqyu@shmu.edu.cn.
Xiaoyan ShenSchool of Pharmacy, Fudan University, Shanghai, 201203, PR China. shxiaoy@fudan.edu.cn.
Fudan University · CN

Funding

National Natural Science Foundation of China (National Science Foundation of China) 81773744
6 · The paper itself

Abstract

Amino-acid metabolism plays a vital role in mammalian target of rapamycin (mTOR) signaling, which is the pivot in colorectal cancer (CRC). Upregulated chaperone-mediated autophagy (CMA) activity contributes to the regulation of metabolism in cancer cells. Previously, we found that sorting nexin 10 (SNX10) is a critical regulator in CMA activation. Here we investigated the role of SNX10 in regulating amino-acid metabolism and mTOR signaling pathway activation, as well as the impact on the tumor progression of mouse CRC. Our results showed that SNX10 deficiency promoted colorectal tumorigenesis in male FVB mice and CRC cell proliferation and survival. Metabolic pathway analysis of gas chromatography-mass spectrometry (GC-MS) data revealed unique changes of amino-acid metabolism by SNX10 deficiency. In HCT116 cells, SNX10 knockout resulted in the increase of CMA and mTOR activation, which could be abolished by chloroquine treatment or reversed by SNX10 overexpression. By small RNA interference (siRNA), we found that the activation of mTOR was dependent on lysosomal-associated membrane protein type-2A (LAMP-2A), which is a limiting factor of CMA. Similar results were also found in Caco-2 and SW480 cells. Ultra-high-performance liquid chromatography-quadrupole time of flight (UHPLC-QTOF) and GC-MS-based untargeted metabolomics revealed that 10 amino-acid metabolism in SNX10-deficient cells were significantly upregulated, which could be restored by LAMP-2A siRNA. All of these amino acids were previously reported to be involved in mTOR activation. In conclusion, this work revealed that SNX10 controls mTOR activation through regulating CMA-dependent amino-acid metabolism, which provides potential target and strategy for treating CRC.

Indexed as

Amino AcidsAnimalsAutophagyCaco-2 CellsCarcinogenesisCell ProliferationCell SurvivalColorectal NeoplasmsHCT116 CellsHumansLysosomal-Associated Membrane Protein 2MaleMetabolomicsMice, KnockoutModels, BiologicalMolecular ChaperonesAmino AcidsLysosomal-Associated Membrane Protein 2Molecular ChaperonesNucleotidesSNX10 protein, humanSNX10 protein, mouseSorting NexinsTOR Serine-Threonine Kinases

Identifiers

PMID29867114
PMCPMC5986761
OpenAlexW2805198304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.